Trial
NCT03933397
Comparing Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Sickle Cell Disease
Intervention
Patient-Specific Protocol
Why stopped
Due to COVID enrollment numbers needed to meet the primary endpoint will not be met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-03